Patent Trial and Appeal Board Denies IPR Petition Aimed at ParkerVision '342 Patent
January 08 2015 - 1:26PM
ParkerVision, Inc. (Nasdaq:PRKR), a developer and
marketer of semiconductor technology solutions for wireless
applications, today announced that on January 8, 2015, the Patent
Trial and Appeal Board ("PTAB") denied institution of trial of all
challenged claims for Inter Partes review ("IPR") of ParkerVision
patent 7,496,342 ("the '342 patent"). The IPR petition was filed in
July, 2014 by RPX Corporation and Michael Farmwald against five
claims of the '342 patent. The '342 patent is one of the four
patents subject to ParkerVision's pending appeal in its patent
infringement case against Qualcomm, Incorporated.
Jeffrey Parker, Chairman and CEO, commented, "We applaud the
PTAB's decision to deny this entire IPR petition. Both the
district court and now the PTAB have rejected questions of validity
with regard to this patent, and we believe that is an appropriate
and just determination. Claim 18 of the '342 patent is
one of the eleven claims that a district court jury found to be
infringed by Qualcomm. Denial of trial institution for this and all
of the other challenged claims of the '342 patent is an extremely
favorable disposition for ParkerVision in its ongoing legal battle
with Qualcomm."
About ParkerVision
ParkerVision, Inc. designs, develops and markets its proprietary
radio-frequency (RF) technologies that enable advanced wireless
solutions for current and next generation communications networks.
Protected by a highly-regarded, worldwide patent portfolio, the
Company's solutions for wireless transfer of RF waveforms address
the needs of a broad range of wirelessly connected devices for high
levels of RF performance coupled with best-in-class power
consumption. For more information please visit
www.parkervision.com. (PRKR-G).
Safe Harbor Statement
This press release contains forward-looking information. Readers
are cautioned not to place undue reliance on any such
forward-looking statements, each of which speaks only as of the
date made. Such statements are subject to certain risks and
uncertainties which are disclosed in the Company's SEC reports,
including the Form 10K for the year ended December 31, 2013 and the
Forms 10Q for the quarters ended March 31, June 30, and September
30, 2014. These risks and uncertainties could cause actual results
to differ materially from those currently anticipated or
projected.
CONTACT: Cindy Poehlman
Chief Financial Officer
ParkerVision, Inc.
904-732-6100, cpoehlman@parkervision.com
or
Don Markley or Glenn Garmont
The Piacente Group
212-481-2050, parkervision@tpg-ir.com
ParkerVision (QB) (USOTC:PRKR)
Historical Stock Chart
From Apr 2024 to May 2024
ParkerVision (QB) (USOTC:PRKR)
Historical Stock Chart
From May 2023 to May 2024